More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy – By Roots Analysis
- Publish Date: April 1, 2021
IoT For All
- Publish Date: April 1, 2021
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.
To order this 500+ page report, which features 185+ figures and 220+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html
The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:
The Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”. report features the following companies, which we identified to be key players in this domain:
Table of Contents
2. Executive Summary
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
New Podcast Episode
Related News
February 4, 2025
January 30, 2025
January 23, 2025